Clinical trial
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the…
NCT00367562 · Hospital Britanico, Other · Completed
Key facts
| NCT number | NCT00367562 |
|---|---|
| Title | Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy |
| Official title | Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy |
| Lead sponsor | Hospital Britanico, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | IGA Nephropathy |
| Intervention type | Drug |
| Interventions | ENALAPRIL VALSARTAN METHYLPREDNISONE |
| Enrollment | 20 |
| Start date | Jan 1, 1996 |
| Completion | Dec 1, 2005 |
| First posted | Aug 23, 2006 |
| Last update posted | Nov 1, 2006 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: